Andrew Dahl, BioMEMS Diagnostics - Portable, In-Vitro Diagnostics Platform | LSI Europe '22

BioMEMS has developed a handheld, portable, in-vitro diagnostics platform that can analyze samples in under 3 minutes. The company's point-of-care platform is capable of analyzing samples from blood, mucus, urine and saliva.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Andrew Dahl
Andrew Dahl
Founder & Chairman, BioMEMS Diagnostics